Renaissance Technologies LLC 13D and 13G filings for Acorda Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 12:35 pm Purchase |
2022-12-30 | 13G | Acorda Therapeutics, Inc. ACOR |
Renaissance Technologies LLC | 43,445 3.570% |
7,737 (+21.67%) |
Filing |
| 2022-02-11 2:20 pm Purchase |
2021-12-31 | 13G | Acorda Therapeutics, Inc. ACOR |
Renaissance Technologies LLC | 35,708 6.380% |
35,708 (New Position) |
Filing |